Skip to content

The MuSt-PC: a Feasibility Study on Intent to Use a Tool With Regard to Symptom Management

The MuSt-PC: A Multidimensional Strategy to Improve Quality of Life of Patients With Multiple Symptoms and Palliative Care Needs - Feasibility Study

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06110624
Enrollment
70
Registered
2023-10-31
Start date
2024-04-18
Completion date
2025-02-28
Last updated
2025-11-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Palliative Medicine

Brief summary

A study on the intent to use a tool (MuSt-PC) to manage symptoms of patients in a palliative care trajectory.

Detailed description

A survey study will be conducted to evaluate if GHCPs have the Intention to Use (IU) MuSt- PC in daily practice. GHCPs are recruited via the connections of the seven Centers of Expertise in Palliative Care. To invite them to participate in the study, the GHCPs are approached directly via e-mail or telephone. Participating GHCPs will be educated on how to use MuSt-PC (educational materials and instruction webinar). GHCPs will be asked to use the CDSS for five individual patients. Every time after using MuSt-PC they will be asked to answer additional questions about their experience with using MuSt-PC in that specific instance. After using MuSt-PC for five patients, they are requested to fill out a comprehensive questionnaire about their overall experiences with using the CDSS.

Interventions

OTHERSurvey

A survey study will be conducted to evaluate if GHCPs have the Intention to Use (IU) MuSt-PC in daily practice.

Sponsors

University Medical Center Groningen
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Healthy volunteers
Yes

Inclusion criteria

Residents (in Dutch: Arts In Opleiding tot Specialist (AIOS) or Arts Niet In Opleiding tot Specialist (ANIOS)), medical specialists and nurse practitioners working in the following disciplines are invited to participate: * General practice * Nursing home * Hospital: * Clinical geriatrics * Medical oncology * Radiation oncology * Pulmonology * Cardiology

Exclusion criteria

HCPs who were formally trained in palliative care (kaderopleiding palliatieve zorg, Masteropleiding Palliative Medicine for Health Care Professionals at Cardiff University or post-HBO opleiding palliatieve zorg) and/or who have been or are currently a consultant of a palliative care consultation team are considered specialists in palliative care, are excluded from participation. GHCPs (e.g. nurses) who cannot independently decide about CDSS recommendation adherence, including drug interventions, are excluded from participation.

Design outcomes

Primary

MeasureTime frameDescription
Questions evaluating Intention to Use (IU)after 5 times use of the MuSt-PC tool within 3 monthsQuestions evaluating Intention to Use (IU) (7-point Likert scales)

Secondary

MeasureTime frameDescription
Questions evaluating other modified TAM domainsafter 5 times use of the MuSt-PC tool within 3 monthsQuestions evaluating other modified TAM domains: Perceived Usefulness, Perceived Ease-of-Use, Attitude, Compatibility, Subjective norm, Facilitators, Habit (7-point Likert Scales).
Perceived benefits and disadvantages of using MuSt-PCafter 5 times use within 3 monthsPerceived benefits and disadvantages of using MuSt-PC (open-ended questions).
Suggestions to improve the MuSt-PC CDSSafter 5 times of the MuSt-PC tool within 3 monthsSuggestions to improve the MuSt-PC CDSS (open-ended question).
Most useful elements of MuSt-PC will be evaluated with a multiple-choice question.after 5 times use within 3 monthsMost useful elements of MuSt-PC will be evaluated with a multiple-choice question. (multiple answers allowed) Frequency and percentage of total respondents who chose the multiple choice answer possibilities will be evaluated
Mean scores of HCPs adherence to CDSS recommendationsafter 5 times use of the MuSt-PC tool within 3 monthsMean scores (5-point Likert scale) of HCPs adherence to CDSS recommendations (each time using MuSt-PC)
An overview of the content of questions of participating GHCPs regarding MuSt-PC use.after 5 times use within 3 monthsAn overview of the content of questions of participating GHCPs regarding MuSt-PC use. Questions will be analyzed qualitatively; coding will be done independently by two researchers. In case of disagreement, consensus will be achieved through discussion. Coding will result in categorization of question subject. Categorizations are ranked from most prevalent to least prevalent question subject (proportion of respondents).

Other

MeasureTime frameDescription
A focus group meeting will be conducted if ≥20% of all participating GHCPs have insufficient intention to use MuSt-PC and/or perceive MuSt-PC insufficiently useful and/or perceive MuSt-PC insufficiently easy to useafter 5 times use of the MuSt-PC tool within 3 monthsA focus group meeting will be conducted if ≥20% of all participating GHCPs have insufficient intention to use MuSt-PC and/or perceive MuSt-PC insufficiently useful and/or perceive MuSt-PC insufficiently easy to use: 1. Insufficient IU is defined as a sum score of ≤12 for the 3 questions that measure Intention to Use by the modified TAM questionnaire (maximum sum score 21) 2. Insufficient PU is defined as a sum score of ≤24 for the 6 questions that measure PU by the modified TAM questionnaire (maximum sum score 42) 3. insufficient PEU is defined as a sum score of ≤24 for the 6 items that measure PEU by the modified TAM questionnaire (maximum sum score 42). (see Appendix G) Six to twelve GHCPs with a sum score of ≤12 (IU) and/or ≤24 (PU and/or PEU) will be invited to participate.

Countries

Netherlands

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026